Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition … Metformin outperforms Paxlovid.

Posted on July 2, 2023 by Jim deMaine

Ed note: A number of doctors are now prescribing Metformin rather than Paxlovid to prevent long COVID–a very interesting change.

To read the article in The Lancet – click here.

What the study showed:

Outpatient treatment with metformin reduced long COVID incidence by about 41%, with an absolute reduction of 4·1%, compared with placebo. Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost, and safe.

This entry was posted in Health. Bookmark the permalink.

1 Response to Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition … Metformin outperforms Paxlovid.

  1. Linda Wolf says:
    July 4, 2023 at 3:25 AM

    WOW ! Then it seems that I am a lucky diabetic who has been on Metformin for years ! Never before have I put the words ‘lucky’ and ‘diabetic’ together. An odd pairing for sure.And even more surprising to me that this medication is being used for long covid. I wonder what the dosage is when used this way.

Comments are closed.